Hepatitis C virus (HCV)-encoded protein p7 is a viroporin that acts as an ion channel and is indispensable for HCV particle production. Although the main target of HCV p7 is the endoplasmic reticulum, it also targets mitochondria. HCV-infected cells show mitochondrial depolarization and ATP depletion; however, the function of HCV p7 in mitochondria is not fully understood. The present study demonstrated that treatment of isolated mouse liver mitochondria with the synthesized HCV p7 protein induced mitochondrial dysfunction. It also demonstrated that HCV p7 targeted isolated mouse liver mitochondria and induced mitochondrial depolarization. In addition, HCV p7 triggered matrix acidification and, ultimately, a decrease in ATP synthesis in isolated mitochondria. These findings indicate that targeting of mitochondria by HCV p7 in infected cells causes mitochondrial dysfunction to support HCV particle production. The present study provided evidence for the role of HCV p7 in mitochondria, and may lead to the development of novel strategies for HCV therapy.
Introduction
Hepatitis C virus (HCV) is one of the common factors associated with development of chronic liver inflammation and liver disease, a major problem in global health. HCV causes not only hepatitis, but also a variety of diseases including liver fibrosis, cirrhosis and hepatocellular carcinoma (HCC) (1) . HCV is a single-stranded RNA virus that encodes several polyproteins; three structural proteins (core, E1, and E2) and seven non-structural proteins (p7, NS2, NS3, NS4A, NS4B, NS5A and NS5B) (2) . It has been reported that these structural proteins constitute the HCV viral particle, and the non-structural proteins serve a variety of roles in the HCV life cycle (2) . However, the exact function and mechanism of HCV polyproteins are not fully understood.
One of the non-structural proteins, p7, has been reported to be a small hydrophobic protein that not only interacts with a variety of biological membranes (3) , but also has ion channel activity as a viroporin (4) . p7 is localized to a variety of cellular organelles, including the endoplasmic reticulum and plasma membrane (3, 5) . A previous study demonstrated that p7 is also localized in mitochondria (4) . This variety of subcellular localizations suggests that p7 has diverse physiological roles in hepatocytes. However, to date, the function of p7 has been mainly discussed with regard to the viral life cycle; for example, the assembly or release of viral particles (6, 7) . In particular, the correlation between p7 and mitochondrial function has not yet been fully elucidated.
Mitochondria are the central organelles of cells. Since mitochondria supply the majority of the cellular energy by oxidative phosphorylation, they serve a key role in energy metabolism in cells. For this reason, mitochondria are often called the 'powerhouses' of cells (8) . Therefore, mitochondrial function is one of the most important factors for cellular function, and the mitochondrial membrane potential (∆Ψm) is a major determinant of the fate of mitochondria and cells (9) . Several studies have suggested that viral infection affects mitochondrial functions, and in particular is correlated with mitochondrial depolarization (10) (11) (12) (13) (14) . It has been reported that certain viroporins, including human T-cell leukemia virus type 1 (HTLV-1) p13 and picornavirus 2B, can be localized on mitochondria and cause mitochondrial depolarization (15, 16) . However, the exact molecular mechanisms of viral infection-induced mitochondrial dysfunction and changes in cell metabolism remain to be elucidated.
A number of studies into HCV infection have previously reported that HCV infection is associated with mitochondrial dysfunction in hepatocytes, and it has been documented that the HCV core protein alters mitochondrial functions in Huh7 and Huh7.5 cells (10, 13, 17) . However, to the best of the authors' knowledge, there is no direct evidence of the association between p7 and liver mitochondria. Therefore, the purpose of the present study was to investigate the exact role of p7 in mitochondrial function. To this end, isolated mouse liver mitochondria and synthesized p7 protein were used in order to investigate the effects of p7.
Materials and methods
Chemicals. Dimethyl sulfoxide, adenosine 5'-diphosphate (ADP), D-mannitol, sucrose, rotenone, ethylene glycol-bis (2-aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA), 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid, magnesium chloride (MgCl 2 ), n-(2-hydroxyethyl) piperazine-n'-2-ethanesulfonic acid) (HEPES), trifluoroethanol (TFE), 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester (BCECF-AM), carbonyl cyanide 3-chlorophenylhydrazone (CCCP) and bovine serum albumin (BSA) were all purchased from Sigma-Aldrich; Merck KGaA (Darmstadt, Germany). Anhydrous monobasic potassium phosphate, (KH 2 PO 4 ), Triton X-100, 5-, 5'-,6-,6'-tetrachloro-1,1', 3,3' tetraethyl benzimidazolyl carbocyanine iodide/chloride (JC-1; M34152), MitoTracker Green FM (M7514), and an ATP determination kit (A22066) were purchased from Thermo Fisher Scientific, Inc. (Waltham, MA, USA). The HCV p7 amino acid sequence (genotype 1a, H77 strain) is ALENLVI LNA 10 ASLAGTHGLV 20 SFLVFFCFAW 30 YLKGRWVPGA 40 VYAFYGMWPL 50 LLLLLALPQR 60 AYA. 5-carboxy-tetramethylrhodamine (TAMRA)-p7 (HCV genotype 1a) was chemically synthesized by GL Biochem (Shanghai, China) and dissolved in TFE.
Animals. The experimental procedures were approved by the Institutional Animal Care and Use Committee of the Korea University College of Medicine (KOREA-2016-0174). Adult male C57 BL/6 N mice (6 weeks old; weight, 16-21 g) were purchased from Orient Bio Inc. (Gyenggi-do, South Korea). Mice were housed in regulated conditions (21±2˚C; 50±5% humidity; 12 h/12 h light/dark cycle with light on from 8 AM) with free access to food and water.
Isolation of mitochondria. All isolation steps were performed on ice or using ice-cold isolation buffers (IB: 225 mM mannitol, 75 mM sucrose and 30 mM Tris-HCl, pH 7.4; IB-1: 0.5% BSA and 0.5 mM EGTA in IB; IB-2: 0.5% BSA in IB) and the mitochondrial sample was prepared as described in (18) . Briefly, following the decapitation of the mice, the livers (0.8 g ± 5%) were washed with IB buffer and cut into small pieces. Liver tissue was homogenized with a glass-tissue grinder (Wheaton Industries Inc., Millville, NJ, USA) in IB-1 buffer, and crude mitochondrial fractions were isolated from suspensions by density-gradient centrifugation (10,000 x g at 4˚C) for 10 min. Mitochondrial pellets were resuspended in mitochondrial resuspension buffer [MRB: 250 mM mannitol, 5 mM HEPES (pH 7.4) and 0.5 mM EGTA]. All the following experiments were performed within 9 h from the time of mitochondria isolation.
Flow cytometric analysis. Flow cytometric assays to measure ∆Ψm and mitochondrial matrix acidification were performed using the FACSCalibur (BD Biosciences, San Jose, CA, USA) and data were analyzed with FlowJo software version 10.0.7 (Tree Star, Inc., Ashland, OR, USA). Mitochondrial samples were gated according to side scatter and forward scatter to optimize mitochondrial selection. For each sample, ~300 events/sec were counted, up to 20,000 counts. Isolated mitochondrial samples were incubated in a buffer composed of 250 mM mannitol, 5 mM HEPES (pH 7.4), 1 mM KH 2 PO 4 , 10 µM EGTA and 2 µM rotenone at room temperature.
Confocal microscopy of isolated mouse liver mitochondria.
Isolated mitochondria were incubated with 0.1 µM TAMRA-p7 for 5 min to target mitochondria and stained with 0.1 µM MitoTracker Green FM for 5 min at room temperature. The samples were loaded onto a cover glass with a confocal dish, and confocal microscopy was performed in a dedicated room at a constant temperature (24±2˚C) and humidity (~40%). The data were acquired using a Zeiss LSM 700 microscope (Zeiss GmbH, Jena, Germany).
Spectrophotometric assay of ∆Ψm. Mitochondrial samples were treated with p7 protein (1 µg/ml) for 5 min and then incubated with JC-1 (1 µM) for 10 min and transferred to black 96-well plates (Optiplate-96F; PerkinElmer, Inc., Waltham, MA, USA) for the measurement of fluorescence at 488 nm excitation. The fluorescence was detected at emission wavelengths of 525 nm (monomers) and 594 nm (aggregates). The mitochondrial membrane potentials were measured using a microplate reader (Molecular Devices, LLC, Sunnyvale, CA, USA).
ATP assay. For the ATP assay, 10 µM ADP and 5 mM succinate were added to the mitochondrial samples (8 µg/ml) for 10 min at room temperature. The samples were subsequently incubated with ATP assay mix (Thermo Fisher Scientific, Inc.) for 15 min, and ATP was measured using a GloMax 20/20 luminometer (Promega Corporation, Madison, WI, USA). ATP amounts were calculated from an ATP standard curve.
Results
The p7 protein targets isolated mouse liver mitochondria. Previous studies have demonstrated that p7 localizes to mitochondria (5); however, the exact role of p7 in mitochondria is difficult to clarify due to the mixed activity of various HCV-encoded proteins. Therefore, an experimental system was designed using isolated mouse liver mitochondria and synthesized p7 protein to clarify its function in mitochondria. First, a flow cytometric assay was performed with a mitochondria-sensitive probe (MitoTracker Green FM) to check the quality of isolated mitochondria. As demonstrated in Fig. 1A , the proportion of mitochondria in the prepared sample was >90%. Next, the mitochondria were treated with the synthesized p7 protein. To visualize the p7 protein, p7 labeled with TAMRA was used and the mitochondrial targeting of p7 examined by flow cytometry. As expected, p7 was detected in mitochondria and the targeting efficiency was ~75% (Fig. 1B) . p7 targeting to mitochondria was also confirmed using confocal laser microscopy (Fig. 1C) .
p7 induces mitochondrial depolarization. The ∆Ψm is an important factor determining the fate of the mitochondria, and therefore of the cells. It has previously been demonstrated that HCV infection of hepatoma cells reduces ∆Ψm (10, 13, 17) . However, the role of p7 in mitochondrial dysfunction in cells infected by HCV has not been reported. To address this, whether p7 affected the ∆Ψm in isolated mitochondria from normal hepatocytes was tested. To investigate the direct effect of p7 in mitochondria, the mitochondria were treated with p7 protein, and the ΔΨm change was examined using a mitochondria-sensitive fluorescent probe (JC-1), which is an indicator of mitochondrial membrane potential. First, the time for JC-1 staining to measure the mitochondrial membrane potential was optimized. As demonstrated in Fig. 2A , the intensity ratio of red/green fluorescence reached a maximum level within 10 min. p7 treatment reduced the ΔΨm in a concentration-dependent manner (Fig. 2B ). Fig. 2C shows the quantified data of Fig. 2B by representing the ratio of the signal of high ΔΨm to the signal of low ΔΨm. To confirm this result, ΔΨm was also examined using a spectrophotometric assay. As demonstrated in Fig. 2D, p7 noticeably induced mitochondrial depolarization. CCCP was used as a positive control ( Fig. 2B-D) .
p7 induces mitochondrial matrix acidification. The proton motive force between the mitochondrial matrix and intermembrane space is determined predominantly by the ΔΨm in mitochondria, and to a lesser extent, by the hydrogen ion (H + ) concentration gradient (9) . These two components contribute to the electrochemical proton gradient and are important for mitochondrial function. Therefore, changes in mitochondrial matrix pH were examined using the fluorescence indicator, BCECF-AM (19, 20) . To determine the optimal staining duration for BCECF-AM in isolated mitochondria, flow cytometric assays with BCECF-AM were performed. As demonstrated in Fig. 3A , the mitochondrial samples were saturated by BCECF-AM fluorescence within 10 min; this indicated a stable pH level of the isolated mitochondria. Matrix acidification triggered by p7 was examined by flow cytometric analysis in mitochondrial samples, and this revealed that the pH of the mitochondrial matrix was decreased by p7 treatment in a concentration-dependent manner ( Fig. 3B and C) . These results demonstrated that p7 caused acidification of the mitochondrial matrix. p7 decreases mitochondrial ATP production. The findings above demonstrated that p7 induced mitochondrial depolarization and mitochondrial matrix acidification. Subsequently, the effect of p7 on mitochondrial ATP production was measured, since ΔΨm is known to be the driving force for ATP synthesis, and an electrochemical hydrogen ion gradient also contributes to the ATP synthesis process (9) . As expected, ATP production was decreased by p7 treatment in a concentration-dependent manner (Fig. 4) . On the basis of results obtained in the present study, it is suggested that the p7 protein directly targets mitochondria to induce mitochondrial dysfunction.
Discussion
Previous studies have reported that disruption of ΔΨm was induced by HCV infection in Huh7.5 cells, and that HCV infection affected mitochondrial functions, including the redox system, calcium signaling and ATP generation (12, 14, 21) . To date, the involvement of HCV p7 in mitochondrial dysfunction has been not reported, although p7 is known to target to mitochondria (5) . Therefore, the aim of the present study was to investigate the direct effects of p7 in mitochondria. To minimize the contribution of indirect effects of p7 in mitochondria, purified mitochondria from mouse liver and synthesized p7 protein were used. It was identified that p7 induced mitochondrial depolarization (Fig. 2) , matrix acidification ( Fig. 3 ) and decreased ATP synthesis (Fig. 4) , clearly demonstrating that p7 serves a direct role in mitochondrial dysfunction. Other HCV-encoded proteins, including the core protein and NS5A, are also associated with mitochondria and affect mitochondrial dysfunction (10, 13) . It was difficult to demonstrate that p7 was a major factor in HCV infection-induced mitochondrial dysfunction. Nonetheless, it has been demonstrated that p7 specifically targeted the purified mitochondria, and had a clear effect on mitochondrial function.
The results of the present study demonstrated that p7 treatment caused mitochondrial matrix acidification ( Fig. 3) . HCV p7 has been reported to function as a proton channel (22) , and thus could affect mitochondrial matrix acidification. However, it was assumed that p7-induced mitochondrial matrix acidification was a small aspect of p7-induced mitochondrial depolarization, since p7 may also conduct other cations, including sodium and potassium ions. It is suggested that p7-induced mitochondrial depolarization is the sum of ion gradient dissipation of protons and a potassium gradient.
It was also demonstrated that p7 affected ATP synthesis in mitochondria (Fig. 4) . The results of the present study are in accord with those reported in earlier experimental studies in hepatocytes (14, 23, 24) . To the best of the authors' knowledge, however, this is the first demonstration of a direct association between HCV p7 and mitochondria. Nevertheless, the phenomenon of HCV infection-induced ATP depletion remains controversial. Normally, the energy requirement increases in virus-infected cells for synthesis of the viral proteins, whereas p7-induced mitochondrial depolarization and the proton gradient dissipation lead to a mitochondrial energy crisis. It has been reported that certain viral infections induce a significant decrease in ATP concentration in hepatoma cell lines (16) . In addition, these viral proteins induce mitochondrial disruptions and, in certain cases, cellular death. Since p7 serves an important role in HCV maturation and budding, but not RNA replication, this phenomenon could be explained by the concept of a 'viral budding strategy' to induce mitochondria-mediated apoptosis at late stages of HCV infection, including the viral budding process.
In conclusion, the present study suggested that HCV p7 serves an important role in mitochondrial dysfunction. The findings have enhanced our understanding of the function of p7 in mitochondria. Although further studies are required to determine the exact mechanism and topology of p7 in the mitochondrial membrane, the findings of the present study may aid the development of future HCV therapies. 
